A machine learning-driven framework accurately predicts MPA exposure and supports individualized dosing in childhood-onset LN.
A new study published in Lupus Science & Medicine discusses how machine learning (ML) opens new possibilities for studying lupus disease, from building predictive models, identifying new biomarkers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results